• Sign up to our Free Newsletter
  • Contact Us
  • Editorial Submission
Microbiome Times Magazine
  • Human Health
  • Finance
  • Drug Database
    • Login
    • About
  • Issue Archive
  • Advertise
  • Recruitment Marketing

Pharma & Human Health

Pharma & Human Health

New microbiome insights could help boost immunotherapy for a range of rare cancers

March 4, 2024 Microbiome Times

Researchers from the Wellcome Sanger Institute, the Olivia Newton-John Cancer Research Institute in Australia, and collaborators, have identified specific strains of bacteria that are linked with a positive response to combination immunotherapy in the largest […]

Finance

DNASense ApS Acquired by Clinical Microbiomics

March 4, 2024 Microbiome Times

Clinical Microbiomics announced the acquisition of DNASense ApS, an innovative Danish microbiome CRO specialized in long-read DNA and RNA sequencing technologies, and the associated cutting-edge bioinformatics. The acquisition expands Clinical Microbiomics’ expertise and offering for […]

Finance

Neobe Therapeutics Raises Over $2m For Synthetic Biology Enabled Tumour Microenvironment Remodelling

March 1, 2024 Microbiome Times

Neobe Therapeutics, a pioneering synthetic biology startup at the forefront of immuno-oncology innovation, is thrilled to announce the successful closure of a $2.34M financing round. This significant financial milestone was achieved with the support of […]

Finance

EIC selects Gedea Biotech for €2.5M grant funding for development of their antibiotic free treatment for vaginal infections

March 1, 2024 Microbiome Times

Yesterday, the EIC announced that Gedea Biotech has been selected for the €2.5M EIC Accelerator grant for the continued development and commercialization of pHyph, an antibiotic free treatment for vaginal infections. The funding will accelerate the […]

Editor's Choice

Women’s Health: The Next Microbiome Frontier

February 20, 2024 Daniel Quinn

Women’s Health & the Microbiome Women’s health refers to a collection of conditions experienced exclusively by women such as pregnancy or menopause, or experienced differently by women than men, such as heart disease and anxiety. […]

Finance

Navigating microbiome innovations: Strategic partnerships in Live Biotherapeutic product development

February 14, 2024 Aaron B Cowley

LBPs represent a paradigm shift in the approach to healthcare. Unlike traditional pharmaceuticals, LBPs harness the power of live microorganisms to influence and rebalance the intricate mechanisms of the microbiome within the body. Their impact […]

Finance

Evogene and Verb Biotics Enter Collaboration Agreement to Advance Probiotic Innovation

February 8, 2024 Microbiome Times

Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a leading computational biology company targeting to revolutionize life-science product development across multiple market segments, and Verb Biotics LLC., a microbiome health ingredient company whose mission is to improve human health, […]

Finance

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

February 8, 2024 Microbiome Times

Synlogic, Inc. (Nasdaq: SYBX), a biopharmaceutical company advancing novel therapeutics to transform the care of serious diseases, announced today the decision to discontinue Synpheny-3, its ongoing pivotal study of labafenogene marselecobac (SYNB1934) as a potential treatment […]

Editor's Choice

New technology unscrambles the chatter of microbes

February 7, 2024 Microbiome Times

Researchers from University of California San Diego, as part of a large collaboration with scientists around the world, have developed a new search tool to help researchers better understand the metabolism of microorganisms. Microbes are […]

Editor's Choice

Researchers discover link between stress and the gut virome

February 5, 2024 Microbiome Times

Researchers at APC Microbiome Ireland (APC), a world-leading SFI research centre based in University College Cork (UCC), have made a world-first discovery in the role the human virome plays in stress management. The findings support […]

Finance

Microbiome Drug Development: 2023 in review

January 19, 2024 Luis Gosálbez & Andrea Almagro

Introduction Twenty twenty three marked a difficult year for the entire biopharmaceutical sector, with reduced funding across the field. Despite this difficulty, microbiome drug development companies became more creative and collaborative than ever, with partnership […]

Posts navigation

« 1 … 13 14 15 … 85 »

Download the MT Forum Agenda:

Sign Up to Free Newsletter

NEW WHITEPAPER: ORAL DELIVERY OF LIVE BIOTHERAPEUTIC PRODUCTS:

Editor’s Choice

  • Siolta Therapeutics Reports Positive Phase 2 Results from the ADORED Study
    November 17, 2025
  • The OMNIgene™•VAGINAL device – Optimized solutions for vaginal microbiome studies
    November 12, 2025
  • MRM Health Raises €55 Million Series B to Advance Microbiome-Based Biotherapeutic Product Pipeline
    September 4, 2025
  • Targeting the ileo-colonic region: Innovative solutions for sensitive APIs
    August 21, 2025
  • EXPERT’Biome CDMO by Lallemand at Microbiome Times Forum
    June 23, 2025
sign up

Sign up to the Microbiome Times newsletter